Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06667037 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 42% 194 → 112 participants
See other at-risk trials from Zhongshan Ophthalmic Center, Sun Yat-sen University

Record History

  1. Enrollment reduced: 194 → 112 participants
    • Enrollment closed, study ongoing
    • Study completion moved earlier from Mar 31, 2027 to Dec 31, 2026
    • Site details revised
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 30, 2024 to Sep 21, 2024
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this multicenter randomized clinical trial is to evaluate the myopia control effect of orthokeratology and 0.01% atropine sequential treatment in children and adolescents, as compared to continuous treatment with orthokeratology.
Trial Details
NCT Number NCT06667037
Lead Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Collaborators: People's Hospital of Guangxi, Henan Provincial People's Hospital, Tianjin Medical University Eye Hospital
Conditions
(from sponsor)		 Myopia
Related terms Myopia
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov